Clear Harbor Asset Management LLC bought a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,025 shares of the medical research company’s stock, valued at approximately $397,000. Other […]
Charles River Laboratories International (NYSE:CRL – Free Report) had its price target raised by Citigroup from $190.00 to $215.00 in a report issued on Monday morning, Benzinga reports. They currently have a neutral rating on the medical research company’s stock. Other analysts have also issued research reports about the company. Evercore ISI decreased their price […]
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eleven ratings firms that are covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average […]
Sei Investments Co. Increases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Vestmark Advisory Solutions Inc. increased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.9% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,370 shares of the medical research company’s stock after purchasing an additional 1,434 shares […]